ArticleCureus2025
New-Onset Systemic Lupus Erythematosus Complicated by Preeclampsia, HELLP Syndrome, and Lupus Nephritis During a Third-Trimester Pregnancy: A Case Report.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Systemic lupus erythematosus (SLE) is a chronic autoimmune disease that primarily affects women of reproductive age. Most patients are diagnosed prior to conception; however, new-onset SLE during pregnancy is rare and can mimic common obstetric complications, delaying diagnosis and treatment. Such overlap increases the risk of maternal morbidity and adverse pregnancy outcomes (APOs). A primigravida adolescent in her third trimester presented with severe preeclampsia, HELLP syndrome, and nephrotic-range proteinuria. Postpartum, she developed hemorrhage requiring a modified B-Lynch suture in the ICU, along with vulvar edema, discoid skin lesions, joint pain, and photosensitivity. Laboratory evaluation revealed positive antinuclear antibodies, anti-double-stranded DNA antibodies, hypocomplementemia (characterized by low levels of C3 and C4), and proteinuria, confirming the diagnosis of new-onset SLE with lupus nephritis. The clinical course was managed with corticosteroids, hydroxychloroquine, and supportive therapy. This case highlights the diagnostic complexity of autoimmune disease in pregnancy, particularly when clinical manifestations overlap with obstetric emergencies such as HELLP syndrome and preeclampsia. It underscores the need for early consideration of SLE in atypical or multisystem presentations, prompt biomarker testing, and timely initiation of immunosuppressive therapy. Management in a specialized center, with a multidisciplinary team, is essential to optimizing maternal and neonatal outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.